|
|
- ProRhythm, Inc. Seeks Restructuring
Release Date: December 12, 2007
- ProRhythm Initiates U.S. Pivotal Trial for HIFU Ablation System
focusAF Study Evaluates HIFU Treatment for Atrial Fibrillation
Release Date: January 11, 2007
- Ting Pau
Oei Joins ProRhythm’s Board of Directors
Release Date:
February 16, 2006
- Approval
of U.S. Pivotal Trial for HIFU Ablation System
Approval Marks Start of Multi-Center Trial for the Treatment of Atrial
Fibrillation
Release Date: January 4, 2006
- ProRhythm Announces Receipt of European CE Mark for HIFU Ablation
System
Regulatory approval clears path toward European commercialization
Release Date:August 15, 2005
- ProRhythm
Announces $25 Million Investment by St. Jude Medical
Agreements Includes European Distribution Rights and Option to Acquire ProRhythm
Released January 5, 2005
- Nancy
Briefs Joins ProRhythm’s Board of Directors
Released December 23, 2004
- ProRhythm, Inc. Announces First Use of Steerable HIFU Ablation
Catheter
Eight patients successfully treated in Hamburg, Germany
Released December 21, 2004
- Transurgical, Inc. Changes Name to ProRhythm, Inc.
New Name Reflects Focus on Treatment of Atrial Fibrillation
Release Date: May 19, 2004
- Transurgical, Inc. Initiates Clinical Trial for Atrial Fibrillation
in the U.S.
1st patient in HIFU Ablation Study successfully treated in
Oklahoma
Release Date: April 30, 2004
- Transurgical, Inc. Receives Certification to ISO 13485:2003
Moves Closer to Commercialization of Atrial Fibrillation Ablation
System
Release Date: April 20, 2004
 |
This
type of file requires the Adobe Reader.
Visit Adobe.com to
download the latest version of Adobe Reader. |
|
|
